Ablating Barrett's metaplastic epithelium: are the techniques ready for clinical use?

Bergman, J. J. G. H. M.; Fockens, P.
September 2006
Gut;Sep2006, Vol. 55 Issue 9, p1222
Academic Journal
The article discusses the use of endoscopic ablation techniques for treatment of Barrett's oesophagus (BO). Discharge of reflux of gastric and duodenal contents into the oesophagus hinders malignant transformation in BO. An ideal ablation technique in BO should remove all dysplasia and intestinal metaplasia. The neosquamous mucosa developing after ablation should be devoid of oncogenetic abnormalities. An ideal ablation technique should target mucosa without harming deeper layers.


Related Articles

  • CELL CYCLE PHASE DISTRIBUTION IN NEOPLASTIC PROGRESSION OF BARRETT'S OESOPHAGUS. Lao-Sirieix, P.; Brais, R.; Coleman, N.; Fitzgerald, R. // Gut;Apr2004 Supplement 3, Vol. 53, pA26 

    It has been demonstrated that there is an increased proliferation index as the Barrett's oesophagus (BE) mucosa progresses through the metaplasia-dysplasia-adenocarcinoma sequence. Understanding of the cell cycle phase distribution in BE could shed light on the basic abnormalities leading to...

  • Role of retinoid X receptor mRNA expression in Barrett's esophagus Brabender, Jan; Lord, Reginald V.; Metzger, Ralf; Park, JiMin; Salonga, Dennis; Danenberg, Kathleen D.; Hölscher, Arnulf H.; Danenberg, Peter V.; Schneider, Paul M.; Hölscher, Arnulf H // Journal of Gastrointestinal Surgery;May2004, Vol. 8 Issue 4, p413 

    The Barrett''s multistage process is characterized histopathologically by progression from Barrett''s intestinal metaplasia to Barrett''s esophagus with dysplasia and ultimately adenocarcinoma. Understanding of the molecular alterations in this multistage process may contribute to improved...

  • Preferred location for the development of esophageal adenocarcinoma within a segment of intestinal metaplasia. Theisen, J.; Stein, H. J.; Feith, M.; Kauer, W. K. H.; Dittler, H. J.; Pirchi, D.; Siewert, J. R. // Surgical Endoscopy;Feb2006, Vol. 20 Issue 2, p235 

    Background: Barrett's metaplasia is the predominant precursor for the development of esophageal adenocarcinoma. This precancerous lesion has become the focus of various surveillance programs aimed at detecting earlier and therefore potentially curable lesions. However, sampling...

  • Meta-Analyses of the Effect of Symptoms of Gastroesophageal Reflux on the Risk of Barrett's Esophagus. Taylor, Justin B.; Rubenstein, Joel H. // American Journal of Gastroenterology;Aug2010, Vol. 105 Issue 8, p1730 

    OBJECTIVES:Esophageal adenocarcinoma (EAC) is a devastating disease that has risen in incidence over the past several decades. Barrett's esophagus (BE) is an associated premalignant lesion. Current preventative efforts rely on endoscopic screening of individuals with gastroesophageal reflux...

  • BARRETT'S ESOPHAGUS: WHAT'S NEW AND WHAT TO DO. Spechler, Stuart Jon // American Journal of Gastroenterology;Mar1989, Vol. 84 Issue 3, p220 

    Presents a study on the prevalence of Barrett's esophagus or the condition in which an abnormal columnar mucosa replaces the squamous epithelium of the distal esophagus. Factors that might contribute to complications in Barrett's esophagus; List of proposed pathogenetic factors for Barrett's...

  • Short Segment Barrett's Esophagus: Clinical and Histological Features, Associated Endoscopic Findings, and Association with Gastric Intestinal Metaplasia. Weston, Allan P.; Krmpotich, Philip; Makdisi, Walid F.; Cherian, Rachel; Dixon, Anita; McGregor, Douglas H.; Banerjee, Sushanta K. // American Journal of Gastroenterology;May1996, Vol. 91 Issue 5, p981 

    Objectives: To prospectively determine the clinical features, associated esophageal endoscopic lesions, associated gastric intestinal metaplasia, and prevalence of dysplasia and adenocarcinoma of short segment Barrett's. Methods: All patients undergoing upper endoscopy over a 5-month period were...

  • Systematic Four-Quadrant Biopsy Detects Barrett's Dysplasia in More Patients Than Nonsystematic Biopsy. Abela, Jo-Etienne; Going, James J.; Mackenzie, John F.; McKernan, Margaret; O'Mahoney, Sylvia; Stuart, Robert C. // American Journal of Gastroenterology;Apr2008, Vol. 103 Issue 4, p850 

    AIMS: To compare detection of Barrett's dysplasia and adenocarcinoma by systematic versus nonsystematic surveillance biopsy protocols. METHODS: Upper GI consultation and open-access endoscopy are provided jointly at Glasgow Royal Infirmary by medical and surgical teams. The surgical team adopted...

  • Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia- adenocarcinoma sequence. Jian-Chun Cai; Di Liu; Kai-Hua Liu; Hai-Ping Zhang; Shan Zhong; Ning-Sao Xia; Montiel-Jarquin, Alvaro // World Journal of Gastroenterology;7/7/2008, Vol. 14 Issue 25, p4070 

    AIM: To investigate the microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence. METHODS: Forty-one specimens were obtained from esophageal cancer (EC) patients. Histopathological assessment identified 23 squamous cell...

  • Utilization of Cytokeratins 7 and 20 Does Not Differentiate between Barrett’s Esophagus and Gastric Cardiac Intestinal Metaplasia. Mohammed, I. A.; Streutker, C. J.; Riddell, R. H. // Modern Pathology;Jun2002, Vol. 15 Issue 6, p611 

    Long segment Barrett's esophagus (LSBE) is a recognized risk factor for the development of esophageal dysplasia and carcinoma. However, the risk of dysplasia arising within intestinal metaplasia below a normal-appearing Z-line (i.e., in native cardiac mucosa) is unknown. Regular endoscopic...


Read the Article


Sign out of this library

Other Topics